title: Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.
authors.affiliation: Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168. pasquale.fedele@monashhealth.org.|Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia. pasquale.fedele@monashhealth.org.
authors.forename: Pasquale L
authors.initials: PL
authors.lastname: Fedele
authors.affiliation: Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.
authors.forename: Gareth P
authors.initials: GP
authors.lastname: Gregory
authors.affiliation: Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.
authors.forename: Michael
authors.initials: M
authors.lastname: Gilbertson
authors.affiliation: Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.|School of Clinical Sciences at Monash Health, Faculty of Medicine, Dentistry and Health Sciences, Monash University, Clayton, Australia.
authors.forename: Jake
authors.initials: J
authors.lastname: Shortt
authors.affiliation: Pathology Department, Monash Medical Centre, Clayton, Australia.
authors.forename: Beena
authors.initials: B
authors.lastname: Kumar
authors.affiliation: Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.|School of Clinical Sciences at Monash Health, Faculty of Medicine, Dentistry and Health Sciences, Monash University, Clayton, Australia.
authors.forename: Stephen
authors.initials: S
authors.lastname: Opat
authors.affiliation: Monash Haematology, Monash Medical Centre, Level 4, 246 Clayton Road, Clayton, VIC, Australia, 3168.|School of Clinical Sciences at Monash Health, Faculty of Medicine, Dentistry and Health Sciences, Monash University, Clayton, Australia.
authors.forename: George
authors.initials: G
authors.lastname: Grigoriadis
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000069286:Bortezomib / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D055104:Infusions, Subcutaneous / Q000379:methods; D008297:Male; D000069293:Plasmablastic Lymphoma / Q000175:diagnosis* / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D000069286:Bortezomib; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone